Publications by authors named "K Bihan"

Claim this Profile
O
Ocrelizumab-induced neutropenia: severity, recurrence, and management. A French national pharmacovigilance study.
Vincent Brochard, Benjamin Le Vavasseur, Sylvine Pinel, Kevin Bihan, Delphine Bourneau Martin

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.
Victor Mirleau, Alex Hlavaty, Etienne-Marie Jutant, Florence Hennegrave, Kévin Bihan

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.
Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum, Kevin Bihan, Elise Dumas

Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.
Léonard Laurent, Baptiste Abbar, Kevin Bihan, Elise Dumas, Floriane Jochum

Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous adverse drug reactions induced by anticonvulsants: Proposal for allergological work-up and contraindications.
Saskia Ingen-Housz-Oro, Paola Sanchez-Pena, Bénédicte Lebrun-Vignes, Kevin Bihan, Claire Bernier

Therapie· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis